The double-strand break-free approach increased functional GATA2 alleles and improved the engraftment of edited blood stem cells in mice ...

Targeted lipid nanoparticles generate CAR NK cells in mice, showing activity against cancer and autoimmune liver disease ...

John Wichelt discusses Kindeva’s Bridgeton facility, supporting injectable programs from clinical development through ...

Thoughtful label design and digital tools can help participants with dyslexia find and access essential clinical trial ...

An RNA sequencing and machine learning screening platform identified an RNA-processing factor that reduced markers of ...

First-in-human study demonstrates the potential of rapidly manufactured trispecific CAR T cells to deliver durable remissions ...

Piers Ingram discusses the resurgence of immunology, engineering-led drug discovery, and why faster clinical execution will shape the next generation of medicines ...

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers ...

Challenges remain in demonstrating value to investors in a capital-constrained environment within the industry. The Power List 2026 features 60 individuals recognized for their contributions, with 20 ...

Cell and gene therapy processes built for early trials may not always be ready for commercial supply, where consistency, capacity, cost, analytics, and quality systems become harder to separate. In ...

WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas. This content is an ...

WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas. To highlight the FDA ...